Drug profile · INN
nesiritide
NATRECOR
nesiritide (NATRECOR) is a atrial natriuretic peptide receptor a agonist. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — nesiritide
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 1
- Programs
- 0
- Data quality
- 0.84
Quick answer
nesiritide (NATRECOR) is a atrial natriuretic peptide receptor a agonist. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Atrial natriuretic peptide receptor A agonist
Primary target: Atrial natriuretic peptide receptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related patents
Frequently asked questions
What is nesiritide?
nesiritide (NATRECOR) is a atrial natriuretic peptide receptor a agonist. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for nesiritide?
NATRECOR is a marketed brand name for nesiritide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nesiritide?
nesiritide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.